Post-Ozempic patients may eat more calories, Deutsche Bank survey finds

Ozempic and Wegovy have been cheered for helping people shed unwanted pounds, but the findings of a recent poll underscore the challenges patients face.

Related Keywords

Novo Nordisk Ozempic ,Deutsche Bank ,Novo Nordisk ,Stock Markets ,Investment Strategy ,Breaking News Investing ,Novo Nordiska S ,Eli Lilly And Co ,Mondelez International Inc ,Kraft Heinz Co ,Nestle Sa ,Unilever Plc ,Compute Health Acquisition Corp ,Business News ,